XT
NIVF

XTX Topco’s NewGenIvf NIVF Stock Holding History

XTX Topco’s Portfolio NIVF Stock Details NIVF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.54K Buy
+1,563
New +$18.1K ﹤0.01% 4053
2025
Q2 		– Hold
0
– -$7.21K – 3309
2025
Q1 		– Hold
0
– – – 2281
2024
Q4 		– Hold
0
– – – 1978
2024
Q3 		– Hold
0
– – – 1921

Other funds holding NIVF

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

XTX Topco's NIVF Position: Q2 2026 in Review

XTX Topco opened a new position in NewGenIvf (NIVF) in Q2 2026: 1,563 shares worth $7.54K. The stake represents ﹤0.01% of the portfolio and ranks #4053 among its holdings.

5 funds tracked by Wall St. Rank hold NIVF as of Q2 2026.

  • XTX Topco held 1,563 shares of NewGenIvf worth $7.54K as of Q2 2026.
  • NewGenIvf was a new XTX Topco position in Q2 2026.
  • NewGenIvf made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #4053 holding.
  • 5 funds tracked by Wall St. Rank held NewGenIvf as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.